Author: Nishio, Naoki; Hiramatsu, Mariko; Goto, Yukari; Shindo, Yuichiro; Yamamoto, Takanori; Jingushi, Naruhiro; Wakahara, Keiko; Sone, Michihiko
Title: Surgical Strategy and Optimal Timing of Tracheostomy in Patients with COVID-19: Early Experiences in Japan Cord-id: er2dtfpd Document date: 2020_11_19
ID: er2dtfpd
Snippet: OBJECTIVE: : Tracheostomy is an important surgical procedure for coronavirus disease-2019 (COVID-19) patients who underwent prolonged tracheal intubation. Surgical indication of tracheostomy is greatly affected by the general condition of the patient, comorbidity, prognosis, hospital resources, and staff experience. Thus, the optimal timing of tracheostomy remains controversial. METHODS: : We reviewed our early experience with COVID-19 patients who underwent tracheostomy at one tertiary hospital
Document: OBJECTIVE: : Tracheostomy is an important surgical procedure for coronavirus disease-2019 (COVID-19) patients who underwent prolonged tracheal intubation. Surgical indication of tracheostomy is greatly affected by the general condition of the patient, comorbidity, prognosis, hospital resources, and staff experience. Thus, the optimal timing of tracheostomy remains controversial. METHODS: : We reviewed our early experience with COVID-19 patients who underwent tracheostomy at one tertiary hospital in Japan from February to September 2020and analyzed the timing of tracheostomy, operative results, and occupational infection in healthcare workers (HCWs). RESULTS: : Of 16 patients received tracheal intubation with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, five patients (31%) received surgical tracheostomy in our hospital. The average consultation time for surgical tracheostomy was 7.4 days (range, 6 - 9 days) from the COVID-19 team to the otolaryngologist. The duration from tracheal intubation to tracheostomy ranged from 14 to 27 days (average, 20 days). The average time of tracheostomy was 27 min (range, 17 - 39 min), and post-wound bleeding occurred in only one patient. No significant differences in hemoglobin (Hb) levels were found between the pre- and postoperative periods (mean: 10.2 vs. 10.2 g/dl, p = 0.93). Similarly, no difference was found in white blood cell (WBC) count (mean: 12,200 vs. 9,900 cells /μl, p = 0.25). After the tracheostomy, there was no occupational infection among the HCWs who assisted the tracheostomy patients during the perioperative period. CONCLUSION: : We proposed a modified weaning protocol and surgical indications of tracheostomy for COVID-19 patients and recommend that an optimal timing for tracheostomy in COVID-19 patients of 2 - 3 weeks after tracheal intubation, from our early experiences in Japan. An experienced multi-disciplinary tracheostomy team is essential to perform a safe tracheostomy in patients with COVID-19 and to minimize the risk of occupational infection in HCWs.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and long term mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and low upper respiratory: 1
- acute respiratory failure and adequate oxygenation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute respiratory failure and adequate pulmonary function: 1
- acute respiratory failure and long term mortality: 1, 2, 3, 4, 5, 6, 7
- acute respiratory failure and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- acute respiratory illness and adequate oxygenation: 1, 2
- acute respiratory illness and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7
- acute respiratory illness pandemic and adequate oxygenation: 1, 2
- acute sars cov respiratory syndrome coronavirus and adequate cough: 1
- acute sars cov respiratory syndrome coronavirus and adequate oxygenation: 1, 2, 3, 4, 5, 6, 7, 8
- acute sars cov respiratory syndrome coronavirus and long term mortality: 1, 2, 3, 4, 5, 6, 7, 8
- acute sars cov respiratory syndrome coronavirus and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute sars cov respiratory syndrome coronavirus and low upper respiratory: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date